ナチュラルキラー細胞治療法の世界市場:NK細胞療法、NK細胞向け抗体...市場調査レポートについてご紹介

【英文タイトル】Natural Killer Cells Therapeutics Market by Therapeutics (NK Cell Therapies and NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), and End User (Research Centers & Institutes, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2026

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Rise in incidence of cancer across the globe
3.5.1.2. Increase in government expenditure on healthcare
3.5.1.3. Surge in awareness regarding immunotherapy

3.5.2. Restraints

3.5.2.1. High cost of cancer immunotherapy treatment
3.5.2.2. Stringent government regulations toward approval of immunotherapy

3.5.3. Opportunity

3.5.3.1. Surge in R&D activities toward the development of immunotherapy

3.6. Government regulatory scenerio

3.6.1. U.S.
3.6.2. Europe
3.6.3. Japan
3.6.4. Thailand
3.6.5. Singapore
3.6.6. Malaysia
3.6.7. Mexico
3.6.8. Australia

CHAPTER 4: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY THERAPEUTICS

4.1. Overview

4.1.1. Market and forecast

4.2. Natural killer cell therapies

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.2.3.1. CNDO-109
4.2.3.2. oNKord
4.2.3.3. Natural Killer Cells
4.2.3.4. Others

4.3. NK cell-directed antibodies

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.3.3.1. MOGAMULIZUMAB
4.3.3.2. Lirilumab
4.3.3.3. AFM13
4.3.3.4. NKTT 120
4.3.3.5. Others

CHAPTER 5: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast, by region

5.2. Cancer

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Gastrointestinal diseases

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

5.4. Immunoproliferative disorders

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country

5.5. Others

5.5.1. Market size and forecast
5.5.2. Market analysis, by country

CHAPTER 6: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY END USER

6.1. Overview

6.1.1. Market and forecast

6.2. Research centers and institutes

6.2.1. Market and forecast, by region
6.2.2. Market analysis, by country

6.3. Hospitals and clinics

6.3.1. Market and forecast, by region
6.3.2. Market analysis, by country

6.4. Others

6.4.1. Market and forecast, by region
6.4.2. Market analysis, by country

CHAPTER 7: NATURAL KILLER CELL THERAPEUTICS MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by therapeutics
7.2.3. Market size and forecast, by application
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by country

7.2.5.1. U.S. market size and forecast, by therapeutics
7.2.5.2. U.S. market size and forecast, by application
7.2.5.3. U.S. market size and forecast, by end user
7.2.5.4. Canada market size and forecast, by therapeutics
7.2.5.5. Canada market size and forecast, by application
7.2.5.6. Canada market size and forecast, by end user
7.2.5.7. Mexico market size and forecast, by therapeutics
7.2.5.8. Mexico market size and forecast, by application
7.2.5.9. Mexico market size and forecast, by end user

7.3. Europe

7.3.1. Key market trends and opportunities
7.3.2. Market size and forecast, by therapeutics
7.3.3. Market size and forecast, by application
7.3.4. Market size and forecast, by end user
7.3.5. Market size and forecast, by country

7.3.5.1. UK market size and forecast, by therapeutics
7.3.5.2. UK market size and forecast, by application
7.3.5.3. UK market size and forecast, by end user
7.3.5.4. Germany market size and forecast, by therapeutics
7.3.5.5. Germany market size and forecast, by application
7.3.5.6. Germany market size and forecast, by end user
7.3.5.7. France market size and forecast, by therapeutics
7.3.5.8. France market size and forecast, by application
7.3.5.9. France market size and forecast, by end user
7.3.5.10. Italy market size and forecast, by therapeutics
7.3.5.11. Italy market size and forecast, by application
7.3.5.12. Italy market size and forecast, by end user
7.3.5.13. Spain market size and forecast, by therapeutics
7.3.5.14. Spain market size and forecast, by application
7.3.5.15. Spain market size and forecast, by end user
7.3.5.16. Rest of Europe market size and forecast, by therapeutics
7.3.5.17. Rest of Europe market size and forecast, by application
7.3.5.18. Rest of Europe market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by therapeutics
7.4.3. Market size and forecast, by application
7.4.4. Market size and forecast, by end user
7.4.5. Market size and forecast, by country

7.4.5.1. Japan market size and forecast, by therapeutics
7.4.5.2. Japan market size and forecast, by application
7.4.5.3. Japan market size and forecast, by end user
7.4.5.4. China market size and forecast, by therapeutics
7.4.5.5. China market size and forecast, by application
7.4.5.6. China market size and forecast, by end user
7.4.5.7. Australia market size and forecast, by therapeutics
7.4.5.8. Australia market size and forecast, by application
7.4.5.9. Australia market size and forecast, by end user
7.4.5.10. India market size and forecast, by therapeutics
7.4.5.11. India market size and forecast, by application
7.4.5.12. India market size and forecast, by end user
7.4.5.13. Rest of Asia-Pacific market size and forecast, by therapeutics
7.4.5.14. Rest of Asia-Pacific market size and forecast, by application
7.4.5.15. Rest of Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by therapeutics
7.5.3. Market size and forecast, by application
7.5.4. Market size and forecast, by end user
7.5.5. Market size and forecast, by country

7.5.5.1. Brazil market size and forecast, by therapeutics
7.5.5.2. Brazil market size and forecast, by application
7.5.5.3. Brazil market size and forecast, by end user
7.5.5.4. Saudi Arabia market size and forecast, by therapeutics
7.5.5.5. Saudi Arabia market size and forecast, by application
7.5.5.6. Saudi Arabia market size and forecast, by end user
7.5.5.7. South Africa market size and forecast, by therapeutics
7.5.5.8. South Africa market size and forecast, by application
7.5.5.9. South Africa market size and forecast, by end user
7.5.5.10. Rest of LAMEA market size and forecast, by therapeutics
7.5.5.11. Rest of LAMEA market size and forecast, by application
7.5.5.12. Rest of LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. AFFIMED N.V.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. CELGENE CORPORATION

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments

8.3. FATE THERAPEUTICS INC.

8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Product portfolio
8.3.4. Business performance
8.3.5. Key strategic moves and developments

8.4. FORTRESS BIOTECH

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Product portfolio
8.4.4. Business performance
8.4.5. Key strategic moves and developments

8.5. GLYCOSTEM THERAPEUTICS BV

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Key strategic moves and developments

8.6. INNATE PHARMA SA

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments

8.7. NANTKWEST INC

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments

8.8. NKARTA THERAPEUTICS, INC.

8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments

8.9. NKT THERAPEUTICS INC.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio

8.10. ZIOPHARM ONCOLOGY INC.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments


【レポート販売概要】

■ タイトル:ナチュラルキラー細胞治療法の世界市場:NK細胞療法、NK細胞向け抗体
■ 英文:Natural Killer Cells Therapeutics Market by Therapeutics (NK Cell Therapies and NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), and End User (Research Centers & Institutes, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2026
■ 発行日:2019年7月
■ 調査会社:Allied Market Research
■ 商品コード:AMR9NV088
■ 調査対象地域:グローバル
  • Petrominerales Ltd.:石油・ガスバリューチェーン分析レポート2013
    Petrominerales Ltd. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Petrominerales Ltd." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Petrominerales Ltd.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
  • 量子暗号の世界市場予測(~2022年):ハードウェア、ソフトウェア
    “Quantum cryptography market projected to grow at a CAGR of 27.0% during the forecast period”The global quantum cryptography market size is expected to grow from USD 285.7 million in 2017 to USD 943.7 million by 2022, at a CAGR of 27.0%. With the growing incident of cyber-attacks, increasing data security and privacy concerns, rising adoption of cloud storage and computing technologies, and evolvi …
  • 扇風機の世界市場予測・分析2020-2024
    Global Electric Fans Market: About this market Technavio’s electric fans market analysis considers sales from ceiling fans, floor fans, and wall-mounted fans. Our study also finds the sales of electric fans in APAC, Europe, MEA, North America, and South America. In 2019, the ceiling fans segment had a significant market share, and this trend is expected to continue over the forecast period. Factor …
  • 乳癌治療用モノクローナル抗体の世界市場
    Breast cancer incidences are increasing across the globe and conventional therapeutics have modest pharmacological efficacy. To surmount this issue, investigators came forth with monoclonal antibodies for breast cancer treatment which have targeted capabilities along with higher safety and efficacy levels. They have found that some receptors have overexpressed in cancerous cells due to which they …
  • K-12教育向け技術の東南アジア市場2016-2020
    About K-12 Education Technology The AEC was established with an aim to transform the ASEAN into a production base with a high competitive advantage and stability over the rest of the world. The community focuses on the economic, political, and socio-cultural development of its 10-member states. A major focus is on improving tertiary education and employability in the region. The conducive conditio …
  • 不応性急性骨髄性白血病:グローバル臨床試験レビュー(2014年上半期)
    Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Refractory Acute Myeloid Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Refractory Acute Myeloid Leukemia. It i …
  • 世界のナイロン樹脂市場2015
    The Global Nylon Resins Industry Report 2015 is a professional and in-depth study on the current state of the Nylon Resins industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Nylon Resins market analysis is provided for the international markets including development trends, competitive landscape anal …
  • ヒト免疫不全ウイルス(HIV)-1治療法の世界市場分析:薬の種類別(ヌクレオシドアナログ逆転写酵素阻害剤(NRTI)、非NRTI、侵入・融合、プロテアーゼ、インテグラーゼ阻害剤、補助受容体拮抗薬)、セグメント予測、2014-2025
    The global HIV-1 therapeutics market is expected to reach a value of USD 15.8 billion by 2025, growing at a CAGR of 1.4%. According to a new report by Grand View Research, Inc., HIV continues to be one of the most challenging public health issues worldwide. The key factors responsible for driving the market growth include the increasing incidence of HIV infections especially amongst the youth due …
  • 航空機の機体構成品の世界市場:胴体、翼、尾部
    About the Commercial Airframe Components Market Aircraft components such as empennage, wings, fuselage, undercarriage, pistons, and turbine engines are made of individual parts that operate in a closed orientation. One of the major problems faced by aircraft designers is to strike a balance in the weight-to-strength ratio in a manner that the aircraft weighs less but has enough strength to withsta …
  • 世界の癌治療用キナーゼ阻害剤市場:Brc-Abl阻害剤/EGFR阻害剤/血管新生阻害剤/BRAF・MEK阻害剤/mTOR阻害剤など
    Kinase inhibitors – a new study showing you trends, R&D and predicted revenues Do you want to find sales potentials of kinase inhibitors? Now get the latest analysis for those cancer treatments. There you explore developments, other trends, results, opportunities and revenue forecasts. Visiongain’s new report shows you what’s possible for drugs using protein kinase inhibition and related technolog …
  • 圧縮空気式電力貯蔵システムの世界市場2015-2019
    About Compressed Air Energy Storage Compressed air energy storage, as the name suggests, is a technique for storing energy by using compressed air. Energy is generally stored for utilizing it later to meet the high demand during peak hours. Growing interest in energy storage by utilizing renewable energy source has led to an upsurge in new and more advanced energy storage techniques. Compressed ai …
  • 整形外科向けソフトウェアの世界市場:術前計画ソフトウェア、電子カルテ、PACS
    Orthopedic software is used before, during and after orthopedic surgeries by surgeons. While there are different types of software used by orthopedic surgeons, digital templating software is most widely used, as they enable advanced orthopedic surgical planning. Orthopedic EHR and orthopedic picture archiving and communication systems (PACS) are also some of the other software preferred by orthope …
  • ウェアラブルパッチの世界市場2016-2020:通常ウェアラブルパッチ、コネクテッドウェアラブルパッチ
    About Wearable Patches Wearable patches can be affixed to the skin and can be worn for a few hours to a couple of weeks. These patches are used for the treatment and delivery of medications such as nicotine. They are also used as anti-aging patches. The connected wearable patches feature wireless connectivity, in addition to the features of regular wearable patches, which help in monitoring the he …
  • Location as a Service (LaaS)
    Location as a Service is a complex derivative of the cloud services concept while being a natural business extension for corporations that have built their operating foundations on GIS, mapping, and navigation. Additionally, a great number of small companies are enabling Location as a Service (LaaS). Why are they jumping in full-force with VC backing and what are the challenges they will endure? W …
  • 世界の商用航空機市場動向2013-2023:市場規模及び成長要因
    The global commercial aircraft sector is expected to experience slow and stable growth during the forecast period. According to Boeing’s estimates, airline companies around the world are expected to procure approximately 34000 airplanes during 2011-2031.
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。